Texas Arthritis Center

El Paso, Texas 79902

4 studies enrolling now · 7 studies all time

What they study most

Juvenile Psoriatic Arthritis, Lupus Erythematosus, Systemic, Lupus Nephritis, Nephritis, Lupus, Psoriatic Arthritis, Systemic Lupus Erythematosus

Studies at this site

• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants — Recruiting now
• PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis — Recruiting now
• A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment — Recruiting now
• Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA). — Recruiting now
• Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients — Recruiting now
• A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Erythematosus — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With Systemic Lupus Erythematosus — Running, not enrolling